Skip Navigation

Sharing Knowledge.

Supporting People.

Advancing Care.

About the Bronchiectasis and NTM Association

The Bronchiectasis and NTM Association is dedicated to improving the lives of people affected by bronchiectasis and NTM lung disease. The Association is committed to advancing high-quality, specialized care, research, education, support, and advocacy within the bronchiectasis and NTM lung disease communities, helping people live longer, healthier lives.

Latest Activity

Read the latest activity from our blog, press releases and BronchandNTM360social, our online community.

Latest Blog Post

Blog

What Is the Bronchiectasis and NTM Care Center Network?

This blog post was authored by Lucinda Shore and reviewed by the Bronchiectasis and NTM Content Review and Evaluation Committee.As bronchiectasis and nontuberculous mycobacterial (NTM) lung disease become more common in the U.S., getting a quick, accurate diagnosis and expert care is very important. To help meet this need, the Bronchiectasis and NTM Association created the Bronchiectasis and NTM Care Center Network (CCN).The CCN connects people to medical centers throughout the U.S. that provide expert care and treatment, high-quality education, advice, and support for those living with bronchiectasis and NTM lung disease. The CCN gives sites one of two designations:Care Center: These centers offer a clinical research program, treat hundreds of people with bronchiectasis and NTM, and provide direct access to specialists (like dietitians or psychologists) for immediate care.Clinical Associate Center (CAC): CACs provide high-quality, expert care, but may see fewer people with both conditions, may be less involved in research, and may not have access to specialists within the center.

Read More
Abstracts

Press Release

Bronchiectasis and NTM Association announces Externally-Led Patient-Focused Drug Development meeting for non-cystic fibrosis bronchiectasis

The Bronchiectasis and NTM Association today announced plans for an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting for non-cystic fibrosis bronchiectasis (NCFB). This meeting is modeled after the Food & Drug Administration’s (FDA) PFDD public meetings. Drug developers, FDA, and other stakeholders will be in attendance.NCFB is a chronic lung disease characterized by inflammation and chronic infection in which the airways become abnormally widened, thickened, and/or scarred. Once considered rare, NCFB is now recognized more widely as awareness, research, and advances in imaging have improved understanding of the disease. Although the first FDA-approved treatment for NCFB became available in 2025, significant challenges remain. Many people still face delays in diagnosis, limited access to specialized care, and difficulties managing the disease’s daily impact.The NCFB EL-PFDD meeting will:Enhance understanding of how living with NCFB impacts daily life experiences;Capture diverse perspectives of the NCFB community to help foster timely and effective therapy development; andInform regulatory decision-making with insights on current care and treatment benefit needs.

Read More
360Social

Discussion

When Should A BNTM Patient See an Audiologist?

When Should a BNTM Patient See an Audiologist?Did you know that hearing health is an important part of managing Bronchiectasis and Nontuberculous Mycobacterial (NTM) lung disease? For some BNTM patients, an audiologist can be an important member of the healthcare team.Why is hearing monitoring important? Certain antibiotics used to treat NTM infections can cause ototoxicity (inner-ear damage).This can affect:👂 Hearing, including permanent hearing loss.🔔 Tinnitus (ringing or buzzing in the ears).⚖️ Balance and coordination.🚶 Vestibular function, which helps us maintain our balance.When should you see an audiologist? Consider an audiology evaluation:Before starting treatment: Establish a baseline hearing test before beginning potentially ototoxic medications such as IV or inhaled amikacin.During treatment: Have regular hearing assessments, as your medical team recommends, to identify changes early.After treatment: Continue monitoring because hearing changes can sometimes appear or progress after treatment has ended.If symptoms develop: Don’t ignore ringing in your ears, muffled hearing, difficulty understanding conversations, dizziness, or balance problems.What tests might an audiologist perform? Depending on your treatment and symptoms, testing may include:Pure-tone hearing testing.High-frequency audiometry.Speech recognition testing.Otoacoustic emissions (OAE).Vestibular testing when balance problems are present.Don’t wait until you notice a hearing problem. Early detection can help your medical team make informed treatment decisions. ❤️ Your lungs are important. Your hearing is important. Your overall quality of life matters, too!Have you had a baseline hearing test before starting Amikacin or other BNTM drugs? Share your experience to help educate other members of our BNTM community.Sent from my iPhone

Read More

New Bronchiectasis Diagnoses

Approximately 70,000 adults are newly diagnosed with bronchiectasis each year in the United States. An estimated 350,000 to 500,000 adults in the U.S. currently living with the condition.

8,600+

Bronchiectasis and NTM Research Registry

The Registry connects people with research to advance care. Participants help support clinical trials and accelerate the development of new treatments.

5,100+

BronchandNTM360social Membership

Join our growing online community to find support, ask questions and connect with others.

Monthly giving is an easy and impactful

Make an Impact

Help us move our mission forward and expand trusted education, strengthen advocacy, advance research, and improve care and resources for patients, families, caregivers, and providers.

World Bronchiectasis Day

World Bronchiectasis Day

Observed annually on July 1, World Bronchiectasis Day is a global campaign designed to raise awareness of bronchiectasis.

Stay In Touch

Sign up for our newsletter for information on upcoming events, virtual meetups, new research, treatment tips, and more, delivered straight to your inbox.